DaVita (NYSE:DVA) Sets New 1-Year High – What’s Next?

Posted by on Jun 23rd, 2026

Shares of DaVita Inc. (NYSE:DVA – Get Free Report) reached a new 52-week high on Tuesday . The company traded as high as $215.33 and last traded at $209.6180, with a volume of 754564 shares changing hands. The stock had previously closed at $207.91.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft raised shares of DaVita from a “hold” rating to a “buy” rating and increased their price target for the stock from $126.00 to $220.00 in a report on Wednesday, May 6th. UBS Group increased their target price on shares of DaVita from $190.00 to $235.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. TD Cowen boosted their price target on shares of DaVita from $144.00 to $201.00 and gave the company a “hold” rating in a research report on Monday, May 11th. Truist Financial upped their price target on shares of DaVita from $158.00 to $205.00 and gave the stock a “hold” rating in a report on Friday, May 8th. Finally, Barclays increased their price objective on DaVita from $158.00 to $194.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $199.17.

View Our Latest Report on DaVita

DaVita Price Performance

The business’s 50 day moving average is $183.40 and its two-hundred day moving average is $150.04. The firm has a market capitalization of $13.46 billion, a PE ratio of 19.45, a P/E/G ratio of 0.68 and a beta of 0.91.

DaVita (NYSE:DVA – Get Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.33 by $0.54. The business had revenue of $3.42 billion during the quarter, compared to analyst estimates of $3.36 billion. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. DaVita’s revenue for the quarter was up 6.0% on a year-over-year basis. During the same period in the previous year, the business posted $2.00 earnings per share. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. Analysts expect that DaVita Inc. will post 15.07 EPS for the current fiscal year.

Insiders Place Their Bets

In other DaVita news, CFO Joel Ackerman sold 51,471 shares of the firm’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $192.10, for a total transaction of $9,887,579.10. Following the sale, the chief financial officer owned 132,434 shares in the company, valued at $25,440,571.40. This trade represents a 27.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Kathleen Alyce Waters sold 15,405 shares of DaVita stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $208.40, for a total value of $3,210,402.00. Following the sale, the insider directly owned 109,194 shares of the company’s stock, valued at approximately $22,756,029.60. This trade represents a 12.36% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 1.50% of the company’s stock.

Hedge Funds Weigh In On DaVita

Large investors have recently modified their holdings of the company. Kesler Norman & Wride LLC lifted its position in DaVita by 0.8% in the 1st quarter. Kesler Norman & Wride LLC now owns 6,816 shares of the company’s stock worth $1,048,000 after buying an additional 55 shares during the last quarter. Gen Wealth Partners Inc raised its stake in shares of DaVita by 10.0% during the fourth quarter. Gen Wealth Partners Inc now owns 880 shares of the company’s stock worth $100,000 after acquiring an additional 80 shares in the last quarter. NewEdge Advisors LLC lifted its holdings in shares of DaVita by 20.8% in the 1st quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock worth $78,000 after acquiring an additional 88 shares during the last quarter. Orion Porfolio Solutions LLC boosted its stake in shares of DaVita by 4.4% in the 4th quarter. Orion Porfolio Solutions LLC now owns 2,360 shares of the company’s stock valued at $268,000 after purchasing an additional 99 shares in the last quarter. Finally, Root Financial Partners LLC boosted its stake in shares of DaVita by 128.0% in the 1st quarter. Root Financial Partners LLC now owns 187 shares of the company’s stock valued at $29,000 after purchasing an additional 105 shares in the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

DaVita Company Profile

(Get Free Report)

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.

Featured Articles

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.